Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fulvestrant combinations in postmenopausal metastatic breast cancer
NCT02137837Phase 3Terminated
- Sponsor
- SWOG Cancer Research Network
- Start
- May 2014
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in breast cancer, sponsored by SWOG Cancer Research Network. Started May 2014; status: terminated.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02137837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02137837.